2016Zhonghua neifenmi daixie zazhiRequires access

Dipeptidyl peptidase-4 inhibitor impacts the expression of Bcl-2 and Bax through γ amino acid bwtyric acid in pancreas islets

Ying Dong, Qiang Li, Jingfang Chen, Ping Wang

Open publisher page 0 citations

Abstract

Objective To explore the effects of dipeptidyl peptidase(DPP-4)inhibitor on proteins expression of Bcl-2 and Bax of islet β-cells through increasing the expression of islet γ amino acid butyric acid(GABA). Methods A total of 50 rats of clean grade were studied. Among them, ten rats were randomly selected as normal controls, the remaining forty rats were fed with high-fat diet and then intraperitoneal injection with streptozotocin, the diabetic rats models were then established. Rats were randomly divided into three groups: i.e. diabetic control group, DPP-4 inhibitor group, and antagonist group(DPP-4 inhibitor and GABA receptor antagonist). Six weeks later, blood glucose, serum insulin, glucagon, and the proteins expression of GABA, Bcl-2, and Bax of islet β-cells were measured. Results (1)Compared with diabetic control group, serum insulin was increased(P<0.05), blood glucose and serum glucagon were decreased in DPP-4 inhibitor group(P<0.05). (2)Compared with DPP-4 inhibitor group, serum insulin was decreased(P<0.05), blood glucose and serum glucagon were increased(P<0.05)in antagonist group.(3)Compared with diabetic control group, the expression of GABA was increased(P<0.05), the expression of Bcl-2 protein was increased(P<0.05)in pancreatic β-cells in DPP-4 inhibitor group.(4)Compared with diabetic control group, the expression of GABA in pancreatic β-cells was increased in antagonist group(P<0.05). Compared with DPP-4 inhibitor group, the expression of Bax protein in pancreatic β-cells was increased in antagonist group(P<0.05), while the expression of Bcl-2 protein was decreased(P<0.05). Conclusions DPP-4 inhibitor could increase the secretion of insulin, decrease the secretion of glucagon, up-regulate expression of anti-apoptosis protein Bcl-2, and down-regulate expression of apoptosis protein Bax in pancreatic β-cells through increasing the expression of GABA, inhibiting pancreatic β-cells apoptosis and protecting the damaged β-cells in type 2 diabetic rats. (Chin J Endocrinol Metab, 2016, 32: 227-231) Key words: Dipeptidyl peptidase-4 inhibitor; γ amino acid butyric acid; Bcl-2 protein; Bax protein; Islet β -cell apoptosis

About this research paper

What this paper is about

Objective To explore the effects of dipeptidyl peptidase(DPP-4)inhibitor on proteins expression of Bcl-2 and Bax of islet β-cells through increasing the expression of islet γ amino acid butyric acid(GABA). Methods A total of 50 rats of clean grade were studied. Among them, ten rats were randomly selected as normal controls, the remaining forty rats were fed with high-fat diet and then intraperitoneal injection with streptozotocin, the diabetic rats models were then established. Rats were randomly divided into three groups: i.e. diabetic control group, DPP-4 inhibitor group, and antagonist group(DPP-4 inhibitor and GABA receptor antagonist). Six weeks later, blood glucose, serum insulin, glucagon, and the proteins expression of GABA, Bcl-2, and Bax of islet β-cells were measured. Results (1)Compared with diabetic control group, serum insulin was increased(P<0.05), blood glucose and serum glucagon were decreased in DPP-4 inhibitor group(P<0.05). (2)Compared with DPP-4 inhibitor group, serum insulin was decreased(P<0.05), blood glucose and serum glucagon were increased(P<0.05)in antagonist group.(3)Compared with diabetic control group, the expression of GABA was increased(P<0.05), the expression of Bcl-2 protein was increased(P<0.05)in pancreatic β-cells in DPP-4 inhibitor group.(4)Compared with diabetic control group, the expression of GABA in pancreatic β-cells was increased in antagonist group(P<0.05). Compared with DPP-4 inhibitor group, the expression of Bax protein in pancreatic β-cells was increased in antagonist group(P<0.05), while the expression of Bcl-2 protein was decreased(P<0.05). Conclusions DPP-4 inhibitor could increase the secretion of insulin, decrease the secretion of glucagon, up-regulate expression of anti-apoptosis protein Bcl-2, and down-regulate expression of apoptosis protein Bax in pancreatic β-cells through increasing the expression of GABA, inhibiting pancreatic β-cells apoptosis and protecting the damaged β-cells in type 2 diabetic rats. (Chin J Endocrinol Metab, 2016, 32: 227-231) Key words: Dipeptidyl peptidase-4 inhibitor; γ amino acid butyric acid; Bcl-2 protein; Bax protein; Islet β -cell apoptosis

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the effects of dipeptidyl peptidase(DPP-4)inhibitor on proteins expression of Bcl-2 and Bax of islet β-cells through increasing the expression of islet γ amino acid butyric acid(GABA). Methods A total of 50 rats of clean grade were studied. Among them, ten rats were randomly selected as normal controls, the remaining forty rats were fed with high-fat diet and then intraperitoneal injection with streptozotocin, the diabetic rats models were then established. Rats were randomly divided into three groups: i.e. diabetic control group, DPP-4 inhibitor group, and antagonist group(DPP-4 inhibitor and GABA receptor antagonist). Six weeks later, blood glucose, serum insulin, glucagon, and the proteins expression of GABA, Bcl-2, and Bax of islet β-cells were measured. Results (1)Compared with diabetic control group, serum insulin was increased(P<0.05), blood glucose and serum glucagon were decreased in DPP-4 inhibitor group(P<0.05). (2)Compared with DPP-4 inhibitor group, serum insulin was decreased(P<0.05), blood glucose and serum glucagon were increased(P<0.05)in antagonist group.(3)Compared with diabetic control group, the expression of GABA was increased(P<0.05), the expression of Bcl-2 protein was increased(P<0.05)in pancreatic β-cells in DPP-4 inhibitor group.(4)Compared with diabetic control group, the expression of GABA in pancreatic β-cells was increased in antagonist group(P<0.05). Compared with DPP-4 inhibitor group, the expression of Bax protein in pancreatic β-cells was increased in antagonist group(P<0.05), while the expression of Bcl-2 protein was decreased(P<0.05). Conclusions DPP-4 inhibitor could increase the secretion of insulin, decrease the secretion of glucagon, up-regulate expression of anti-apoptosis protein Bcl-2, and down-regulate expression of apoptosis protein Bax in pancreatic β-cells through increasing the expression of GABA, inhibiting pancreatic β-cells apoptosis and protecting the damaged β-cells in type 2 diabetic rats. (Chin J Endocrinol Metab, 2016, 32: 227-231) Key words: Dipeptidyl peptidase-4 inhibitor; γ amino acid butyric acid; Bcl-2 protein; Bax protein; Islet β -cell apoptosis

Key concepts: Internal medicine, Endocrinology, Antagonist, Pancreas, Streptozotocin, Intraperitoneal injection, Glucagon, Islet

Related papers

Back to paper searchBrowse research topicsOriginal source
Dipeptidyl peptidase-4 inhibitor impacts the expression of Bcl-2 and Bax through γ amino acid bwtyric acid in pancreas islets — Research Paper | ScholarLens